RxDoctor Payments Data

Michael Moghimi, MD

Orthopaedic Surgery · Austin, TXNPI 1063640001

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Spineart USA Inc accounts for 69.4% of it on its own, with 23 other manufacturers making up the rest.

$45,640in general payments, 2019–2025

Across 186 payments — averaging $245.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spineart USA Inc$32K
  • Abbott$4K
  • Intrinsic Therapeutics$3K
  • CTL Medical Corporation$3K
  • Si-bone, Inc.$2K
  • Cerapedics Inc.$546
  • plus $2K from 18 others
$1,500in research payments, 2019–2025

Across 2 payments — averaging $750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Elutia, Inc.$2K

What the payments were for

  • Consulting fees$22,25049%
  • Travel & lodging$12,55128%
  • Food & beverage$10,73924%
  • Education$990%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,640 in reported general payments places this provider in the 85th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024
$572,559
Medicare patients
676
Services billed
4,439

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen126$2,225
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen77$1,168
Gabapentin81$712
Methocarbamol84$638
Methylprednisolone94$638
Cyclobenzaprine Hcl70$461
Meloxicam58$214
Tramadol Hcl35$140
Oxycodone Hcl11$102
Ondansetron Hcl17$91

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Austin

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →